In summary, we confirm CXCR4 expression in the more common subtypes DLBCL, FL and HL but advocate further investigation of this chemokine receptor in MCL and MALT where both pre-clinical and clinical studies are few. Here, CXCR4 is linked to mantle cell lymphoma.